Skip to content
20-F

Annual Report (Foreign)

SHL TELEMEDICINE LTD

0001178913-25-001815

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2024 16.39M sh
Shares Outstanding FY 2024 · Dec 31, 2024 16.39M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$372K
Cash And Equivalents FY 2024 · Dec 31, 2024 $7.68M
Stockholders Equity FY 2024 · Dec 31, 2024 $39.25M
Current Liabilities FY 2024 · Dec 31, 2024 $26.54M
Total Liabilities FY 2024 · Dec 31, 2024 $41.51M
Current Assets FY 2024 · Dec 31, 2024 $27.47M
Total Assets FY 2024 · Dec 31, 2024 $80.76M
Eps Diluted FY 2024 · Dec 31, 2024 −$1.71
Eps Basic FY 2024 · Dec 31, 2024 −$1.71
Rd Expense FY 2024 · Dec 31, 2024 $5.36M
Net Income FY 2024 · Dec 31, 2024 −$27.75M
Operating Income FY 2024 · Dec 31, 2024 −$26.79M
Gross Profit FY 2024 · Dec 31, 2024 $25.79M
Cost Of Revenue FY 2024 · Dec 31, 2024 $30.99M
Revenue FY 2024 · Dec 31, 2024 $56.78M